Taylor Sandison
2020
In 2020, Taylor Sandison earned a total compensation of $792.4K as Chief Medical Officer at Cidara Therapeutics, a 2% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $159,000 |
|---|---|
| Option Awards | $198,563 |
| Salary | $432,000 |
| Other | $2,850 |
| Total | $792,413 |
Sandison received $432K in salary, accounting for 55% of the total pay in 2020.
Sandison also received $159K in non-equity incentive plan, $198.6K in option awards and $2.9K in other compensation.
Rankings
In 2020, Taylor Sandison's compensation ranked 9,537th out of 13,090 executives tracked by ExecPay. In other words, Sandison earned more than 27.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,537 out of 13,090 | 27th |
Division Manufacturing | 4,087 out of 5,621 | 27th |
Major group Chemicals And Allied Products | 1,665 out of 2,254 | 26th |
Industry group Drugs | 1,458 out of 1,954 | 25th |
Industry Biological Products, Except Diagnostic Substances | 338 out of 411 | 18th |
Source: SEC filing on April 29, 2022.
Sandison's colleagues
We found one more compensation record of an executive who worked with Taylor Sandison at Cidara Therapeutics in 2020.
2020
Jeffrey Stein
Cidara Therapeutics
Chief Executive Officer
News
Cidara Therapeutics CEO Jeffrey Stein's 2023 pay jumps 24% to $1.6M
June 3, 2024
Cidara Therapeutics CEO Jeffrey Stein's 2022 pay falls 23% to $1.3M
April 27, 2023
Cidara Therapeutics CEO Jeffrey Stein's 2021 pay jumps 26% to $1.6M
April 29, 2022
Cidara Therapeutics CEO Jeffrey Stein's 2019 pay rises 6% to $1.5M
April 29, 2020
Cidara Therapeutics CEO Jeffrey Stein's 2018 pay falls 25% to $1.4M
April 26, 2019